Finding of invalidity of patents related to methods for determining optimal dosage of thiopurine reversed
Prometheus Laboratories, Inc. v. Mayo Collaborative Services,08-1403, concerned a challenge to the district court’s grant of summary judgment of invalidity of plaintiff’s patents, related to claim methods for determining the optimal dosage of thiopurine drugs to treat gastrointestinal and non-gastrointestinal autoimmune diseases.
Related Link:
- Read the Federal Circuit’s Full Decision in Prometheus Laboratories, Inc. v. Mayo Collaborative Services,08-1403
You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help
Civil Rights
Block on Trump’s Asylum Ban Upheld by Supreme Court
Criminal
Judges Can Release Secret Grand Jury Records
Politicians Can’t Block Voters on Facebook, Court Rules